Growth Metrics

Protalix BioTherapeutics (PLX) EBT Margin Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,558.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,688.00
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 9,954.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9,954.00
Dec 31, 2025 -10,620.00
Sep 30, 2025 -886.00
Jun 30, 2025 2,108.00
Mar 31, 2025 8,938.00
Dec 31, 2024 27,543.00
Sep 30, 2024 3,802.00
Jun 30, 2024 -7,288.00
Mar 31, 2024 -9,566.00
Dec 31, 2023 -17,306.00
Sep 30, 2023 853.00
Jun 30, 2023 11,695.00
Mar 31, 2023 -1,641.00
Dec 31, 2022 4,011.00
Sep 30, 2022 1,048.00
Jun 30, 2022 11,596.00
Mar 31, 2022 3,756.00
Dec 31, 2021 -7,900.00
Sep 30, 2021 658.00
Jun 30, 2021 -13,871.00
Mar 31, 2021 -5,854.00
Dec 31, 2020 84.00
Sep 30, 2020 -1,699.00
Jun 30, 2020 2,506.00
Mar 31, 2020 7,817.00
Dec 31, 2019 31,589.00
Sep 30, 2019 81,218.00
Jun 30, 2019 36,233.00
Mar 31, 2019 9,049.00
Dec 31, 2018 26,813.00
Sep 30, 2018 -68,533.00
Jun 30, 2018 -20,774.00
Mar 31, 2018 35,159.00
Dec 31, 2017 -9,322.00
Sep 30, 2017 977.00
Jun 30, 2017 39,449.00
Mar 31, 2017 77,782.00
Sep 30, 2016 28,966.00
Jun 30, 2016 -14,631.00
Mar 31, 2016 -90,473.00
Mar 31, 2015 -27,632.00
Mar 31, 2014 1,426.00
Dec 31, 2013 107,812.00
Sep 30, 2013 -9,785.00
Jun 30, 2013 -34,135.00
Mar 31, 2013 3,256.00
Dec 31, 2012 -49,247.00
Sep 30, 2012 62,517.00
Jun 30, 2012 185,202.00
Mar 31, 2012 -3,504.00
Dec 31, 2011 37,736.00
Sep 30, 2011 -68,502.00
Jun 30, 2011 -92,561.00